BTIG Research Issues Positive Forecast for HealthEquity (NASDAQ:HQY) Stock Price

HealthEquity (NASDAQ:HQY) had its price target hoisted by BTIG Research from $110.00 to $115.00 in a research note issued to investors on Friday morning, MarketBeat reports. BTIG Research currently has a buy rating on the stock.

Several other equities research analysts have also weighed in on HQY. Citizens Jmp lifted their price objective on HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a report on Monday, June 1st. Weiss Ratings upgraded shares of HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, June 5th. KeyCorp reiterated an “overweight” rating on shares of HealthEquity in a research note on Tuesday, May 26th. Barrington Research reissued an “outperform” rating and set a $110.00 price objective on shares of HealthEquity in a report on Friday, May 22nd. Finally, Wall Street Zen downgraded HealthEquity from a “buy” rating to a “hold” rating in a research note on Saturday, July 4th. Eleven research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $110.93.

HealthEquity Trading Up 0.3%

Shares of HealthEquity stock opened at $94.64 on Friday. The stock has a fifty day simple moving average of $90.21 and a 200 day simple moving average of $84.94. The company has a market capitalization of $7.91 billion, a P/E ratio of 35.45, a price-to-earnings-growth ratio of 1.59 and a beta of 0.21. HealthEquity has a 12-month low of $72.76 and a 12-month high of $105.96. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.13. The business had revenue of $354.64 million for the quarter, compared to analysts’ expectations of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The company’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, sell-side analysts anticipate that HealthEquity will post 3.92 earnings per share for the current fiscal year.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 3,142 shares of the company’s stock in a transaction on Friday, May 29th. The shares were sold at an average price of $95.00, for a total value of $298,490.00. Following the completion of the transaction, the executive vice president directly owned 59,113 shares in the company, valued at approximately $5,615,735. This represents a 5.05% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the business’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $219,510.00. Following the sale, the director owned 19,733 shares in the company, valued at approximately $1,775,970. This trade represents a 11.00% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 17,905 shares of company stock valued at $1,651,280. 1.60% of the stock is currently owned by company insiders.

Institutional Trading of HealthEquity

Hedge funds have recently made changes to their positions in the stock. William Blair Investment Management LLC purchased a new position in shares of HealthEquity in the 4th quarter worth about $169,956,000. Wasatch Advisors LP increased its position in shares of HealthEquity by 10.5% during the second quarter. Wasatch Advisors LP now owns 7,960,735 shares of the company’s stock valued at $719,014,000 after acquiring an additional 757,801 shares in the last quarter. Norges Bank purchased a new position in HealthEquity in the 4th quarter worth approximately $66,927,000. AQR Capital Management LLC lifted its position in HealthEquity by 148.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock valued at $116,016,000 after acquiring an additional 661,795 shares in the last quarter. Finally, Millennium Management LLC lifted its position in HealthEquity by 151.5% in the 4th quarter. Millennium Management LLC now owns 951,563 shares of the company’s stock valued at $87,173,000 after acquiring an additional 573,283 shares in the last quarter. 99.55% of the stock is owned by institutional investors.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.